Physician Awareness and Understanding of Hereditary Angioedema: A Web-based Study in Japa
Not Applicable
- Conditions
- Hereditary Angioedema
- Registration Number
- JPRN-UMIN000042800
- Lead Sponsor
- Takeda Pharmaceutical Company Limited
- Brief Summary
The proportions of physicians in dermatology, pediatrics, emergency medicine, internal medicine, and gastroenterological surgery who were able to select the C1-INH activity test as a diagnosis test for potential HAE patients were 71.8%, 59.7%, 57.1%, 40.3%, and 25.7%, respectively.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 692
Inclusion Criteria
Not provided
Exclusion Criteria
Have less than 1 year of practice excluding training period. Currently participating or planning to participate in any clinical trials and receiving any investigational agents for HAE treatment.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method